EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetically determined body mass index is associated with diffuse large B‐cell lymphoma in polygenic and Mendelian randomization analyses

Amy Moore, Eleanor Kane, Lauren R Teras iD, Mitchell J Machiela, Joshua Arias, Orestis A Panagiotou, Alain Monnereau, Nicole Wong Doo, Zhaoming Wang iD, Susan L Slager, Roel C H Vermeulen, Claire M Vajdic iD und 48 weitere

International Journal of Cancer · 2026

DOI: 10.1002/ijc.70039 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, 2026. Verfasst von Amy Moore und 59 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA. Hauptthemen laut MEDLINE: Lymphoma, Large B-Cell, Diffuse, Body Mass Index, Obesity, Multifactorial Inheritance. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NCI NIH HHS, NCCDPHP CDC HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity has been associated with non‐Hodgkin lymphoma (NHL), but the evidence is inconclusive. We examined the association between genetically determined adiposity and four common NHL subtypes: diffuse large B‐cell lymphoma (DLBCL), follicular lymphoma, chronic lymphocytic leukemia, and marginal zone lymphoma, using eight genome‐wide association studies of European ancestry ( N = 10,629 cases, 9505 controls) and constructing polygenic scores for body mass index (BMI), waist‐to‐hip ratio (WHR), and waist‐to‐hip ratio adjusted for BMI (WHRadjBMI). Higher genetically determined BMI was associated with an increased risk of DLBCL [odds ratio (OR) per standard deviation (SD) = 1.18, 95% confidence interval (95% CI): 1.05–1.33, p = .005]. This finding was consistent with Mendelian randomization analyses, which demonstrated a similar increased risk of DLBCL with higher genetically determined BMI (OR per SD = 1.12, 95% CI: 1.02–1.23, p = .03). No significant associations were observed with other NHL subtypes. Our study demonstrates a positive link between a genetically determined BMI and an increased risk of DLBCL, providing additional support for increased adiposity as a risk factor for DLBCL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, Large B-Cell, DiffuseBody Mass IndexObesityMultifactorial InheritanceHumansMendelian Randomization AnalysisGenome-Wide Association StudyFemaleMaleMiddle AgedCase-Control StudiesPolymorphism, Single NucleotideWaist-Hip RatioGenetic Predisposition to DiseaseAdiposityLymphoma, FollicularLeukemia, Lymphocytic, Chronic, B-CellRisk Factors

Autor:innen und Institutionen

  • Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
  • Department of Health Sciences, University of York, York, UK.
  • Department of Population Science, American Cancer Society, Atlanta, Georgia, USA.
  • Department of Health Services, Policy, and Practice, Brown University School of Public Health, Providence, Rhode Island, USA.
  • Center for Gerontology and Healthcare Research, Brown University School of Public Health, Providence, Rhode Island, USA.
  • Unit of Mixed Research (UMR1153), Centre for Research in Epidemiology and Statistics (CRESS), INSERM, Université Paris-Cité, Paris, France.

ORCID-Profile: Lauren R Teras, Zhaoming Wang, Claire M Vajdic, Immaculata De Vivo, Paolo Boffetta, Angela R Brooks-Wilson, Federico Canzian

Förderung

  • NHLBI NIH HHS
  • NCI NIH HHS
  • NCCDPHP CDC HHS
  • NHGRI NIH HHS
  • WHI NIH HHS
  • NIEHS NIH HHS
  • NCATS NIH HHS
  • NIA NIH HHS

Zitieren

APA

Moore, A., Kane, E., Teras, L. R., Machiela, M. J., Arias, J., Panagiotou, O. A., Monnereau, A., Doo, N. W., Wang, Z., Slager, S. L., Vermeulen, R. C. H., Vajdic, C. M., Smedby, K. E., Spinelli, J. J., Vijai, J., Giles, G. G., Link, B. K., Arslan, A. A., Nieters, A., …, & Ravichandran, V. (2026). Genetically determined body mass index is associated with diffuse large B‐cell lymphoma in polygenic and Mendelian randomization analyses. International Journal of Cancer. https://doi.org/10.1002/ijc.70039

Vancouver

Moore A, Kane E, Teras LR, Machiela MJ, Arias J, Panagiotou OA, et al. Genetically determined body mass index is associated with diffuse large B‐cell lymphoma in polygenic and Mendelian randomization analyses. International Journal of Cancer. 2026. doi:10.1002/ijc.70039

BibTeX
@article{Moore2026,
  author = {Moore, Amy and Kane, Eleanor and Teras, Lauren R and Machiela, Mitchell J and Arias, Joshua and Panagiotou, Orestis A and Monnereau, Alain and Doo, Nicole Wong and Wang, Zhaoming and Slager, Susan L and Vermeulen, Roel C H and Vajdic, Claire M and Smedby, Karin E and Spinelli, John J and Vijai, Joseph and Giles, Graham G and Link, Brian K and Arslan, Alan A and Nieters, Alexandra and Bracci, Paige M and Camp, Nicola J and Salles, Gilles and Cozen, Wendy and Hjalgrim, Henrik and De Vivo, Immaculata and Adami, Hans-Olov and Albanes, Demetrius and Becker, Nikolaus and Benavente, Yolanda and Bisanzi, Simonetta and Boffetta, Paolo and Brennan, Paul and Brooks-Wilson, Angela R and Canzian, Federico and Clavel, Jacqueline and Conde, Lucia and Cox, David G and Curtin, Karen and Foretova, Lenka and Ghesquières, Hervé and Glimelius, Bengt and Habermann, Thomas M and Hofmann, Jonathan N and Lan, Qing and Liebow, Mark and Lincoln, Anne and Maynadie, Marc and McKay, James and Melbye, Mads and Miligi, Lucia and Milne, Roger L and Molina, Thierry J and Morton, Lindsay M and North, Kari E and Offit, Kenneth and Padoan, Marina and Piro, Sara and Patel, Alpa V and Purdue, Mark P and Ravichandran, Vignesh},
  title = {Genetically determined body mass index is associated with diffuse large B‐cell lymphoma in polygenic and Mendelian randomization analyses},
  journal = {International Journal of Cancer},
  year = {2026},
  doi = {10.1002/ijc.70039}
}
Kostenlos starten →